Article
Antitumor drug adozelesin differentially affects active and silent origins of DNA replication in yeast checkpoint kinase mutants.
Cancer research - 1 May 2001
Wang Y, Beerman T A, Kowalski D
Abstract excerpt
The antitumor drug adozelesin is a potent cytotoxic DNA-damaging agent. Here we determined how adozelesin affects chromosomal DNA replication at a molecular level in a yeast model system and examined the influence of checkpoint kinase genes, the human homologues of which are mutated in cancer. Analysis of replication intermediates using two-dimensional gel electrophoresis showed that adozelesin inhibited the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
